Medical Device Reporting (MDR) Requirements the New FDA Draft Guidance
|
|
- Eustace Gaines
- 7 years ago
- Views:
Transcription
1 Medical Device Reporting (MDR) Requirements the New FDA Draft Guidance February 27, 2014 Jeffrey K. Shapiro (202)
2 Essential Requirements n Submit MDR reportable events to FDA (21 CFR (c), ) n Establish and maintain written procedures to review complaints for MDR reportability (21 CFR , ) n Establish and maintain complete MDR files (21 CFR , ) 2
3 Definition of Reportable Event (21 CFR 803.3) n MDR reportable event (or reportable event) means: An event that manufacturers or importers become aware of that reasonably suggests that one of their marketed devices: (i) May have caused or contributed to a death or serious injury, or (ii) Has malfunctioned and that the device or a similar device marketed by the manufacturer or importer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur. 3
4 Elements of an MDR Reportable Event n Manufacturer n becomes aware of information n that reasonably suggests n one of its marketed devices n may have caused or contributed to a serious injury or death OR n malfunctioned and same or similar device would likely cause or contribute to serious injury or death upon if malfunction were to recur 4
5 Preamble statement likely Reporters do not need to assess the likelihood that a malfunction will recur. The fact that the malfunction occurred once leads to the presumption that the malfunction will recur. A malfunction is reportable if any one of the following is true: (1) The chance of a death or serious injury occurring as a result of a recurrence of the malfunction is not remote; 5
6 Draft Guidance likely n If malfunction causes death or serious injury once, it is presumed likely to do so q Subsequent malfunctions must be reported n Must file exemption to lift presumption q Based on investigation of subsequent malfunctions q FDA appears to abandon previous two year presumption guidance 6
7 Requirement to Investigate n Perennial problem sometimes difficult to obtain information, healthcare facility or clinician may be uncooperative n Draft guidance says q Level of effort should relate to nature and severity of the event, rather than just focusing on number of attempts n Many manufacturers have a procedure requiring three attempts q Good faith effort includes at least one written request q Record each attempt and response by reporter 7
8 Requirement to Investigate n Draft guidance recommends focus on q Patient involvement and outcome your ability to capture this information is part of good faith effort q If initial report is for a malfunction, but patient subsequently dies, supplemental report should be submitted for death 8
9 Requirement to Investigate n Draft guidance q Good faith effort does not require specific number of attempts one attempt should be in writing q Try to get the device back n If users do not cooperate, you must still analyze event cannot just close the file n Look at device history, manufacturing processes, similar events 9
10 Exemptions Are Becoming More Important n FDA s position (in warning letters and draft guidance) is that q Manufacturers and importer have duplicate requirement to report death or serious injuries need an exemption to have just one report q Manufacturer and contract manufacturer of the finished device have duplicate reporting requirements absent an exemption n Many firms have allocated responsibility by contract but have not requested exemptions for the nonreporter q This needs to change need a contract allocation and an exemption! 10
11 Delay in Surgery n If your device causes or contributes to a delay in surgery, is it a reportable event? q Maybe! n Draft guidance q Delay not automatically reportable q Need to gather details about impact on the patient s condition to support reporting decision 11
12 Routine Surgical Explants n Draft guidance - not reportable if implant has reached (or is near) its established life expectancy q Unless there is device-related death or serious injury associated with explantation / replacement 12
13 Labeled Incompatibility n Device A s labeling states it is not compatible with Device B n Physician uses them together adverse event n Reportable? q Yes if there is a patient serious injury or death because these are reportable even when caused by user error! q No if there is no patient adverse event but the devices do not work not a malfunction because labeling was not followed, so no malfunction report required 13
14 Diagnostic Devices n If diagnostic device failure indirectly serious injury or death reportable? n Draft guidance yes! 14
15 Difference of Medical Opinion n What is healthcare professionals at facility differ over whether malfunction occurred or device may have caused or contributed to serious injury or death? n Draft guidance says- q You must investigate and determine if information reasonably suggests malfunction / serious injury / death q Evaluate the differences in opinion and explain why you choose one over the other 15
16 Same Patient / Different Days n Draft guidance - same patient experiences adverse events on different days with same device report each as separate submission 16
17 Devices under Investigational Device Exemption (IDE) n Draft guidance q Device X is cleared or approved q Device X is being studied for a second intended use under an IDE q Adverse event occurs in the IDE study n Reportable? q Yes both MDR and IDE reporting requirements apply! 17
18 Foreign Events n Device X is exported under section 801(e) or 802 of the Food, Drug, and Cosmetic Act (so it is not cleared or approved for sale in the US) n Reportable event occurs in the EU n Reportable? q Draft guidance yes but we re going to exercise enforcement discretion q Excepts if a concern has arisen but we ll let you know in writing 18
19 Foreign Events n US manufacturer q Device under IDE study in US q Exported under 801(e) or 802 of the FDCA q Adverse event outside US n Reportable? q Draft guidance yes, but enforcement discretion q But it may be reportable to the IDE program 19
20 Foreign Manufacturer n Draft guidance hypothetical q Foreign manufacturer q US clearance or approval q Marketed outside US q Adverse event outside US n Reportable? q Draft guidance yes even if devices are tweaked to meet different standards outside US q Unless modification is directly involved 20
21 Foreign Manufacturer n Draft guidance hypothetical q Foreign manufacturer q No US clearance or approval, but IDE study q Marketed outside US q Adverse event outside US n Reportable? q Draft guidance no MDR report (might be reportable to IDE program) 21
22 Malfunction Caught Before Use n Draft guidance health care provider notices that device is malfunctioning and intervenes before patient harm can occur n Reportable? q Yes, if it could cause serious injury or death if malfunction were to recur n What if device malfunctions and alarms to alert users? q Draft guidance yes because alarm might not work or there might be no one present to respond 22
23 Sale of 510(k) n Draft guidance hypothetical- q Firm A manufacturers and distributes cleared device q Sells 510(k) to Firm B which takes over manufacture and distribution q Adverse event for device sold by Firm A n Who must report? q Firm A q Or firms could agree that Firm B will report but Firm A needs to apply for an exemption as well 23
24 IMPORTANT LINKS MDR Guidance Document - MDR Preamble Compliance Program Guidance Manual CDRH Learn emdr Draft Guidance utm_campaign=google2&utm_source=fdasearch&utm_medium=website&utm_term=mdr %20Guidance&utm_content=2 24
25 Jeffrey Shapiro (202) Thank You! Visit our firm s top-rated blog: 25
Medical Device Reporting (MDR) 21 CFR Part 803
Medical Device Reporting (MDR) 21 CFR Part 803 1 Objectives Review applicable sections of 21 CFR 803 and 21 CFR 820 Review and explain MDR reporting requirements Review FDA-483 observation examples 2 Medical
More informationSection 5: Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP)
Section 5: Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP) 1 Quality Systems Regulation (QSR) 2 Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP) Sets of checks
More informationAugust 18, 2015. Re: Section 1201 Rulemaking Proposed Exemption for Medical Devices
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 August 18, 2015 Ms. Jacqueline C. Charlesworth General Counsel
More informationMobile Medical Application Development: FDA Regulation
Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 7 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationMedical Device Reporting. Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration
Medical Device Reporting Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration Session Overview Purpose: To provide information about the
More informationClinical trials for medical devices: FDA and the IDE process
Clinical trials for medical devices: FDA and the IDE process Owen Faris, Ph.D. Deputy Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health,
More informationCAPA - the importance of data analysis
CAPA - the importance of data analysis Presented by: Sue Jacobs QMS Consulting, Inc. 1 847 359 4456 sue@qmsconsultant.com QMS Consulting, Inc. 2007 1 Topics Regulatory Requirements Design Controls and
More informationJUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUL 2 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular
More informationFMEA Failure Risk Scoring Schemes
FMEA Failure Risk Scoring Schemes 1-10 Scoring for Severity, Occurrence and Detection CATEGORY Severity 10 9 8 7 6 5 3 2 1 Hazardous, without warning Hazardous, with warning Very High High Moderate Low
More informationCorrections and Removals 21 CFR Part 806
Corrections and Removals 21 CFR Part 806 Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs From the Newsroom
More informationORACLE CONSULTING GROUP
ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739
More informationTopics for today. Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports. Post-marketing Submissions
Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports Martha A. Feldman, RAC Drug & Device Development Co., Inc. Topics for today Post-approval requirements for
More informationFDA Regulation of Hearing Aids. Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic and ENT Devices ODE/CDRH/FDA
FDA Regulation of Hearing Aids Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic ENT ODE/CDRH/FDA U.S. Food Drug Administration Presentation Outline Overview of device regulations riskbased
More informationMobile Medical Applications: FDA s Final Guidance. M. Elizabeth Bierman Anthony T. Pavel Morgan, Lewis & Bockius, LLP
Mobile Medical Applications: FDA s Final Guidance Michele L. Buenafe M. Elizabeth Bierman Anthony T. Pavel Morgan, Lewis & Bockius, LLP 1 Background FDA has a long-standing policy to regulate any computer
More informationChapter 8 WHAT THE STATUTE AND REGULATIONS SAY. Combination Products. Key Points
Chapter 8 Combination Products Suzanne O Shea, Baker & Daniels, LLP, Indianapolis, IN Key Points A combination product comprises two or more different types of regulated components. It can be a drug/device,
More informationSENTINEL EVENTS AND ROOT CAUSE ANALYSIS
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER SENTINEL EVENTS AND ROOT CAUSE ANALYSIS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO.
More informationG. Recalls. http://www.fda.gov/safety/recalls/industryguidance/ucm129259.htm.
G. Recalls 1. Background When an FDA-regulated product is defective, potentially harmful, or mislabeled, recalling that product removing it from the market or correcting the problem is often the most effective
More informationBreakout Sessions: FDA s Regulation of Mobile Health and Medical Applications
Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications 2015 Annual Conference Washington, DC Bakul Patel, Associate Director for Digital Health, Office of Center Director, Center
More informationMedical Device Software
Medical Device Software Bakul Patel Senior Policy Advisor 1 Overview Medical devices and software Oversight principles and Current approach Trends, Challenges and opportunities Addressing challenges 2
More informationCENTER FOR CONNECTED HEALTH POLICY
CENTER FOR CONNECTED HEALTH POLICY The Center for Connected Health Policy (CCHP) is a public interest nonprofit organization that develops and advances telehealth policy solutions to promote improvements
More informationhttp://www.fda.gov/forconsumers/consumerupdates/ucm341344.htm?source=govdelivery.
6 Tip-offs to Rip-offs: Don't Fall for Health Fraud Scams The US Food and Drug Administration has published a paper on how we as consumers and avoid getting ripped off by health fraud scams. This paper
More informationVigilance Reporting. Vicky Medley - Head of QMS, Medical Devices. September 2015. Copyright 2015 BSI. All rights reserved.
Vigilance Reporting Vicky Medley - Head of QMS, Medical Devices September 2015 2 Why? 3 protecting and improving public health https://www.gov.uk/government/organisations/medicines-and-healthcareproducts-regulatory-agency/about
More informationPMAs, 510(k)s, and Advanced IDE Topics
PMAs, 510(k)s, and Advanced IDE Topics Kenneth J. Cavanaugh Jr., Ph.D. Scientific Reviewer Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health kenneth.cavanaugh@fda.hhs.gov
More informationUnited States Department of Health and Human Services Findings on the Permissibility of Reporting to Public Health Authorities under HIPAA
United States Department of Health and Human Services Findings on the Permissibility of Reporting to Public Health Authorities under HIPAA Background DISCLOSURES FOR PUBLIC HEALTH ACTIVITIES [45 CFR 164.512(b)]
More informationPROGRAM 7382.845. Field Reporting Requirements
PROGRAM 7382.845 SUBJECT: INSPECTION OF MEDICAL DEVICE MANUFACTURERS IMPLEMENTATION DATE October 1, 2000 COMPLETION DATE September 30, 2004 DATA REPORTING PRODUCT CODES PRODUCT/ASSIGNMENT CODES 73-91 82845A
More informationMedical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices
Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document
More informationMarketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice
Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice Kurt R. Karst Hyman, Phelps & McNamara, P.C. 700 Thirteenth Street, N.W., Suite 1200 Washington, D.C.
More informationThe Reporting of Adverse Events in Health Care: Minnesota s Law
The Reporting of Adverse Events in Health Care: Minnesota s Law Marie Dotseth, MHA Senior Policy Advisor for Patient Safety Minnesota Department of Health Minnesota Background Minnesota Alliance for Patient
More informationComplaints, Servicing, and FDA Reporting
Complaints, Servicing, and FDA Reporting Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-358-3082 1 Outline Setting the Stage
More informationA New Standard for Medical Device Adverse Event Classification
Vol. 5, No. 12, December 2009 Can You Handle the Truth? A New Standard for Medical Device Adverse Event Classification By Nancy J. Stark Adverse events are defined and managed differently in the device
More informationADMINISTRATIVE POLICY & PROCEDURE RISK MANAGEMENT PLAN (MMCIP)
PAGE #: 1 of 8 CROSS REFERENCES: Administrative Policy PI-01: Unanticipated Adverse Patient Events Administrative Policy PI-04: Patient Safety Plan Administrative Policy PI-07: Incident Reporting System
More informationGuidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)
Guidance s Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationRegulatory Considerations for Medical Device Software. Medical Device Software
Medtec Ireland 2015 Wireless Medical Devices Regulatory Considerations for Medical Device Software Kenneth L. Block, RAC October 7, 2015 Galway, Ireland Offices: Dallas, Texas (12 employees) Tokyo, Japan
More informationRecall Communication: Medical Device Model Press Release Ron Brown
Recall Communication: Medical Device Model Press Release Ron Brown SLIDE 1 Welcome to CDRH Learn. CDRH Learn is a training program developed by FDA's Center for Devices and Radiological Health. It's designed
More informationCHAPTER 7 - RECALL ACTIVITIES
CHAPTER 7 INVESTIGATIONS OPERATIONS MANUAL 2015 CONTENTS CHAPTER 7 - RECALL ACTIVITIES 7.1.1.1 - Recall SUBCHAPTER 7.1 - RECALLS... 368 7.1.1 - DEFINITIONS... 368 7.1.1.1 - Recall... 368 7.1.1.2 - Recall
More informationMedical devices adverse incidents reported to MHRA 2011 to 2013
Medical devices adverse incidents reported to MHRA 2011 to 2013 This summary of medical device adverse incident data replaces the annual reports that we have previously published. Further changes are planned
More informationMedical Software Development. International standards requirements and practice
Medical Software Development International standards requirements and practice Food and Drug Administration What? A public health agency Why? Protect American consumers How? By enforcing the Federal Food,
More informationGuidance for Industry Bar Code Label Requirements Questions and Answers
Guidance for Industry Bar Code Label Requirements Questions and Answers For questions on the content of this guidance, contact the Center for Drug Evaluation and Research or the Center for Biologics Evaluation
More informationReporting Adverse Events and Concerns at Stroger Hospital
Reporting Adverse Events and Concerns at Stroger Hospital Case Pt on coumadin comes in for community acquired pneumonia and is started on levaquin After several days, you note a lot of bruising.. You realize
More informationOn Behalf of: InTouch Health
On Behalf of: InTouch Health White Paper FDA Regulation of Mobile Health Technologies The Current Regulatory Framework as Applied to InTouch Health s Telehealth Solutions June 15, 2012; Updated June 15,
More informationIOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others
IOWA STATE UNIVERSITY Institutional Review Board Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others Introduction This policy details the Institutional Review Board
More informationAugust 21, 2015. TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Mr. Iain Alligan Technical
More informationThe Mammography Quality Standards Act Final Regulations Document #1
Compliance Guidance The Mammography Quality Standards Act Final Regulations Document #1 Document issued on: March 19, 1999 This document supersedes document Draft Compliance Guidance August 27, 1998 U.S.
More informationSUPPORTING STATEMENT FOR Hearing Aid Devices, Professional and Patient Labeling and Conditions for Sale 21 CFR 801.420 and 801.421 OMB No.
A. JUSTIFICATION SUPPORTING STATEMENT FOR Hearing Aid Devices, Professional and Patient Labeling and Conditions for Sale 21 CFR 801.420 and 801.421 OMB No. 0910-0171 1. Circumstances Making the Collection
More informationAmerican Association of Tissue Banks: Impact on FDA s UDI Final Rule
American Association of Tissue Banks: Impact on FDA s UDI Final Rule TOPIC INITIAL FDA PROPOSAL AATB COMMENT FDA FINAL RULE (INCLUDING COMMENTS) ISBT 128 FDA noted the presence of GS1 [which uses the Global
More informationMOBILE MEDICAL APPLICATIONS
October 7, 2013 EVOKE HEALTH POINT OF VIEW MOBILE MEDICAL APPLICATIONS FDA GUIDANCE FOR INDUSTRY FOR MORE INFORMATION: Mark McConaghy, VP, Strategy Evoke Health 267.765.4998 mark.mcconaghy@evokehealth.com
More informationGuidance for Industry
Guidance for Industry FDA Export Certificates Submit comments and suggestions regarding this document at anytime to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
More informationApplication Submitted on Received on Supplement type NDA 021875/S-005 July 24, 2008 July 25, 2008 Changes Being Effected
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 NDA 021875/S-005, S-008, S-015 SUPPLEMENT APPROVAL Cephalon Inc. Attention: Paul Kirsch Senior Director and Group
More informationRegulatory Landscape For Mobile Medical Apps (MMAs)
Regulatory Landscape For Mobile Medical Apps (MMAs) Date: December 6, 2013 Place: Erie County Bar Association, MidDay Learning Program Where value is law. Monika Bhatt mbhatt@hodgsonruss.com Blog: GatewayFDA.com
More informationUNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION
UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION MARCIA OLSON, ) ) Plaintiff, ) ) Case No: v. ) ) HOWMEDICA OSTEONICS CORP. d/b/a ) STRYKER ORTHOPAEDICS, ) JURY TRIAL DEMANDED
More informationTriangle Compounding 11/2/15
Triangle Compounding 11/2/15 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District 60 Eighth Street NE Atlanta, GA 30309 November 2, 2015 VIA UNITED
More informationManifestation Determinations: Legal and Practical Considerations
CSE Chairpersons Technical Assistance Meeting Manifestation Determinations: Legal and Practical Considerations presented by Susan T. Johns, Esq. Ferrara, Fiorenza, Larrison, Barrett & Reitz, P.C. stjohns@ferrarafirm.com
More informationInternational Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update
International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update Kimberly A. Trautman Associate Director, International Affairs Office of the Center Director
More informationMinistero della Salute
Why clinical risk is relevant to patient safety? Workshop on Clinical Risk Management and Management of Adverse Event Belgrade 16-17 December 2013 Dott.ssa Lucia Guidotti Ministry of Health, Department
More informationIACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013
Exempt Sections within the Food, Drug, and Cosmetic Act If a "traditional compounder", defined as a licensed pharmacist or licensed physician, meets ALL conditions within Section 503A, the compounder is
More informationThe U.S. FDA s Regulation and Oversight of Mobile Medical Applications
The U.S. FDA s Regulation and Oversight of Mobile Medical Applications The U.S. FDA s Regulation and Oversight of Mobile Medical Applications As smart phones and portable tablet computers become the preferred
More informationIt s all about managing food. Food Recall Plan Template For Food Manufacturers
It s all about managing food. Food Recall Plan Template For Food Manufacturers What to Do In The Event Of a Product Recall Every Food Distributor and Food Manufacturer must track the products they manufacture
More informationCutting Edge Issues in Health Care Technology & mhealth. Agenda
Cutting Edge Issues in Health Care Technology & mhealth Vernessa Pollard July 2014 Agenda The Regulatory Landscape Jurisdiction and Authority Over Mobile Health Products Requirements, Compliance and Enforcement
More informationAW Server 510 (k) Summary of Safety and Effectiveness
SEP 2 2008 GE Medical Systems AW Server 510 (k) Summary of Safety and Effectiveness This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR
More informationFOOD FACILITIES REGISTRATION OF. Protecting the U.S. Food Supply. What You Need to Know About
U.S. Food and Drug Administration Protecting the U.S. Food Supply U.S. Department of Health and Human Services What You Need to Know About REGISTRATION OF FOOD FACILITIES FDA Food Security Information
More informationINSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER OCCURRENCE VARIANCE REPORT SYSTEM EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
More informationFDA Regulation of Health IT
FDA Regulation of Health IT September 2014 Marian J. Lee Partner +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDA Draft Guidance on Medical Device Data Systems (MDDS),
More informationWhich Apps Does FDA Regulate?
Which Apps Does FDA Regulate? Bradley Merrill Thompson 2015 EPSTEIN BECKER & GREEN, P.C. ALL RIGHTS RESERVED.. 1 Topics for Discussion Which apps does FDA regulate? Enforcement Discretion Pharma Apps Future
More informationGuidance for Industry
Guidance for Industry Medication Guides Adding a Toll-Free Number for Reporting Adverse Events U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
More informationGuidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products
Guidance for Industry Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Small Entity Compliance Guide Written comments and suggestions may be
More informationADDRESSES SYSTEM LOCATION
Volume 80, Number 28 Wednesday, February 11, 2015 Public Notice 9034; Pages 7671 Privacy Act; System of Records: Medical Records, State-24 SUMMARY: Notice is hereby given that the Department of State proposes
More information510(k) Summary GlobalMedia Group, LIC. MAY 0 7 2013 CONiM
510(k) Summary GlobalMedia Group, LIC. MAY 0 7 2013 CONiM Date Prepared: January 8, 2013 Submitter's Information: GlobalMedia Group, LLC 15020 N. 74th St. Scottsdale, AZ 85260 Contact: Nicholas Campbell
More informationTEXAS DEPARTMENT OF STATE HEALTH SERVICES. Executive Summary. Report on Regulation of Laser Hair Removal
TEXAS DEPARTMENT OF STATE HEALTH SERVICES Report on Regulation of Laser Hair Removal DAVID L. LAKEY, M.D. COMMISSIONER CHARGE Study the licensing and certification of laser hair removal facilities, including
More informationJanuary 12, 2016. Dear Amy Yang:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 12, 2016 Amy
More informationAustin Retina Associates Notice of Health Information Practices
Austin Retina Associates Notice of Health Information Practices THIS NOTICE DESCRIBES HOW INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT
More informationFDA Releases Final Cybersecurity Guidance for Medical Devices
FDA Releases Final Cybersecurity Guidance for Medical Devices By Jean Marie R. Pechette and Ken Briggs Overview and General Principles On October 2, 2014, the Food and Drug Administration ( FDA ) finalized
More informationGuidance for Industry
Guidance for Industry Submitting Debarment Certification Statements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document
More informationFinal Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture
Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture CDER Leonard Sacks, Office of Medical Policy Ron Fitzmartin, Office of Strategic Programs Jonathan Helfgott,
More informationFDA Guidance for Industry Update - Process Validation
FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES NDA 17-854 NDA 21-793 NDA 17-862. [inside address] Dear :
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 NDA 17-854 [inside address] Dear : Please refer to your new drug application NDA xx-xxx for
More informationInformation Sheet Guidance For IRBs, Clinical Investigators, and Sponsors
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Frequently Asked Questions About Medical Devices Additional copies are available from: Office of Good Clinical Practice Office
More informationGuidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
More informationGeneral Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff
General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document
More informationHow To Regulate A Medical Device From A Cell Phone
On Behalf of: InTouch Health White Paper FDA Regulation of Mobile Health Technologies The Current Regulatory Framework as Applied to InTouch Health s Telemedicine Solution June 15, 2012 TABLE OF CONTENTS
More informationFDA Regulation of Health IT
FDA Regulation of Health IT May 2014 Marian J. Lee Partner King & Spalding +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDASIA Health IT Report 2 FDA s Mobile Medical
More informationBy Natalia Wilson, MD, MPH
White Paper The value of unique device identification across healthcare By Natalia Wilson, MD, MPH Executive summary The Unique Device Identification (UDI) System Proposed Rule was published by the U.S.
More informationMedical Device Reporting for User Facilities
Medical Device Reporting for User Facilities DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Medical Device Reporting for User Facilities Prepared by Office
More informationOverview. Introduction To The Revised GPSD
KELLER AND HECKMAN LLP Serving Business through Law and Science The Revised EU General Product Safety Directive ( GPSD ) and the EU Product Liability Directive: Considerations for Global Consumer Product
More informationGuidance for Industry
Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments on this draft guidance by
More informationUnique Device Identification System; Final Rule
4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Unique Device Identification System; Final Rule Docket No. FDA-2011-N-0090 Final Regulatory Impact Analysis Final Regulatory
More informationCase 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8
Case 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF FLORIDA UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) v.
More informationGuidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
More informationWHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com
More information0 EC2 92011 V-,) 133 Lj9a
0 EC2 92011 V-,) 133 Lj9a Section 5: 5 1 0(k) Summar 5 10(K) SUMMARY FOR SOMATOM DEFINITION Flash (with Stellar Detector) Submitted by: Siemens Medical Solutions USA, Inc. 51 Valley Stream Parkway Malvern,
More informationUnique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Document issued on August 20, 2014. On November 5, 2014 this document was
More informationFebruary 5, 2015. Dear Kristin Pabst,
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 February 5, 2015, Inc.
More informationStrengthening Our national SyStem for medical device POStmarket Surveillance
Strengthening Our national SyStem for medical device POStmarket Surveillance center for devices and radiological health u.s. food and drug administration SEPTEMBER 2012 table Of contents a InTRoducTIon
More informationIVD Regulation Overview. Requirements to Assure Quality & Effectiveness
IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug
More informationNOTICE OF PRIVACY PRACTICES Effective: September 20, 2013
Livingston Hospital and Healthcare Services 131 Hospital Drive Salem, KY 42078. NOTICE OF PRIVACY PRACTICES Effective: September 20, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE
More informationCONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:
CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: COMPARING AND CONTRASTING FDA MEDICAL DEVICE REGULATIONS FOR CLINICAL INVESTIGATORS WITH ISO 14155:2011 Introduction Today s clinical research landscape for
More informationGE Healthcare MAR 1 2013
K130155 Pagel1 of 2 GE Healthcare MAR 1 2013 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: Submitter: Primary Contact Person: Secondary Contact Person:
More informationThe Shifting Sands of Medical Software Regulation
The Shifting Sands of Medical Software Regulation Suzanne O Shea Ralph Hall September 10, 2014 What Software is Regulated by FDA? FDA regulates medical devices. FDA regulates software that meets the definition
More informationMarch 18, 2013. Discussion Guide
March 18, 2013 Discussion Guide Unique Device Identification (UDI) Implementation Expert Workshop: Accessing & Communicating Device Information: UDI as a Tool for Improved Patient and Provider Connectivity
More information